BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 28536310)

  • 1. The prognostic values of signal transducers activators of transcription family in ovarian cancer.
    Li S; Sheng B; Zhao M; Shen Q; Zhu H; Zhu X
    Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28536310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic roles of signal transducers and activators of transcription family in human breast cancer.
    Wang S; Yu L; Shi W; Li X; Yu L
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 29326301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic values of signal transducers activators of transcription in gastric cancer.
    Zhang Y; Yu C
    Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30944204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic values of
    Chetry M; Li S; Liu H; Hu X; Zhu X
    Biosci Rep; 2018 Apr; 38(2):. PubMed ID: 29472315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mining the prognostic significance and immune infiltration of
    Zhou Y; Jiang S; Yu S; Zhu L; Liu Y; Li S; Hao N; Ren Y
    Gland Surg; 2022 Apr; 11(4):720-741. PubMed ID: 35531108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-depth analysis of the expression and functions of signal transducers and activators of transcription in human ovarian cancer.
    Gong X; Liu X
    Front Oncol; 2022; 12():1054647. PubMed ID: 36524006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signal transducer and activator of transcription family is a prognostic marker associated with immune infiltration in endometrial cancer.
    Zhou XY; Dai HY; Zhang H; Zhu JL; Hu H
    J Clin Lab Anal; 2022 Apr; 36(4):e24315. PubMed ID: 35244291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression profile and prognostic values of STAT family members in non-small cell lung cancer.
    Yang M; Chen H; Zhou L; Chen K; Su F
    Am J Transl Res; 2019; 11(8):4866-4880. PubMed ID: 31497205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STATs profiling reveals predominantly-activated STAT3 in cholangiocarcinoma genesis and progression.
    Dokduang H; Techasen A; Namwat N; Khuntikeo N; Pairojkul C; Murakami Y; Loilome W; Yongvanit P
    J Hepatobiliary Pancreat Sci; 2014 Oct; 21(10):767-76. PubMed ID: 25044480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and survival analysis of the STAT gene family in diffuse gliomas using integrated bioinformatics.
    Wang L; Xu D; Cai L; Dai J; Li Y; Xu H
    Curr Res Transl Med; 2021 May; 69(2):103274. PubMed ID: 33836320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mining database for the therapeutic targets and prognostic biomarkers among STAT family in glioblastoma.
    Li C; Zhou Y; Deng H; Ye Y; Zhao S; Liang S; Cai S; Lin J; Tang Y; Wu Y
    Cancer Biomark; 2021; 30(2):179-191. PubMed ID: 33104022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A family-wide assessment of latent STAT transcription factor interactions reveals divergent dimer repertoires.
    Begitt A; Krause S; Cavey JR; Vinkemeier DE; Vinkemeier U
    J Biol Chem; 2023 May; 299(5):104703. PubMed ID: 37059181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The transcriptional STAT3 is a potential target, whereas transcriptional STAT5A/5B/6 are new biomarkers for prognosis in human breast carcinoma.
    Wu HT; Liu J; Li GW; Shen JX; Huang YT
    Oncotarget; 2017 May; 8(22):36279-36288. PubMed ID: 28422733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pan-cancer analysis reveals signal transducer and activator of transcription (STAT) gene family as biomarkers for prognostic prediction and therapeutic guidance.
    Cheng M; Liu Y; Guo Y; Li M; Xian S; Qin H; Yang Y; Qian W; Tang J; Lu Y; Yao Y; Zhang M; Jin M; Xu L; Huang R; Xu D
    Front Genet; 2023; 14():1120500. PubMed ID: 36968603
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognostic values of S100 family members in ovarian cancer patients.
    Bai Y; Li LD; Li J; Lu X
    BMC Cancer; 2018 Dec; 18(1):1256. PubMed ID: 30558666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential and controversy of targeting STAT family members in cancer.
    Verhoeven Y; Tilborghs S; Jacobs J; De Waele J; Quatannens D; Deben C; Prenen H; Pauwels P; Trinh XB; Wouters A; Smits ELJ; Lardon F; van Dam PA
    Semin Cancer Biol; 2020 Feb; 60():41-56. PubMed ID: 31605750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioinformatics Analysis of Expression Profiles and Prognostic Values of the Signal Transducer and Activator of Transcription Family Genes in Glioma.
    Ji W; Liu Y; Xu B; Mei J; Cheng C; Xiao Y; Yang K; Huang W; Jiao J; Liu H; Shao J
    Front Genet; 2021; 12():625234. PubMed ID: 34276757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic values of the peroxiredoxins family in ovarian cancer.
    Li S; Hu X; Ye M; Zhu X
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30104402
    [No Abstract]   [Full Text] [Related]  

  • 19. Prognostic roles of Notch receptor mRNA expression in human ovarian cancer.
    Chen C; Wang X; Huang S; Wang L; Han L; Yu S
    Oncotarget; 2017 May; 8(20):32731-32740. PubMed ID: 28415574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expressional STAT3/STAT5 Ratio is an Independent Prognostic Marker in Colon Carcinoma.
    Klupp F; Diers J; Kahlert C; Neumann L; Halama N; Franz C; Schmidt T; Lasitschka F; Warth A; Weitz J; Koch M; Schneider M; Ulrich A
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1548-55. PubMed ID: 25773877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.